Scotland · NHS Scotland MSAN
Minims® Oxybuprocaine hydrochloride 0.4% eye drops 0.5ml unit dose
MSAN(2023)18 · Level 3 · issued 29 Aug 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Proxymetacaine 0.5% eye drops 0.5ml unit dose are in limited supply until early October 2023. | Limited supply | early October 2023 |
| 3. Minims® Tetracaine Hydrochloride 0.5% w/v and 1% w/v eye drop solution remain available but | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2023:18
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
f262e9bafce927cedb57474e9087992b047af624ace37a615285aa5270b59aaasha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2023-18.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.